Latest Breaking News On - Cangzhou chuangrong - Page 1 : comparemela.com

Shenzhen-based HighTide Therapeutics is aiming to raise HK$278 million (US$35.6 million) from an IPO in Hong Kong, a fraction of the originally planned US$200 million.

Hong kongChina generalMayer brownJerome powellCangzhou chuangrongAlibaba group holdingYuthai fundYuexiu fundHuatai internationalFederal reserveChina development bank capitalHealthcare fund of guangdongHong kong exchangesRobert luiDeloitte chinaChairman jerome powell